Literature DB >> 24784428

Microbiology: Resistance fighters.

Bill Cannon.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24784428     DOI： 10.1038/509S6a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  What counters antibiotic resistance in nature?

Authors:  Remy Chait; Kalin Vetsigian; Roy Kishony
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

2.  Antibiotic interactions that select against resistance.

Authors:  Remy Chait; Allison Craney; Roy Kishony
Journal:  Nature       Date:  2007-04-05       Impact factor: 49.962

Review 3.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

4.  Structural basis for the drug extrusion mechanism by a MATE multidrug transporter.

Authors:  Yoshiki Tanaka; Christopher J Hipolito; Andrés D Maturana; Koichi Ito; Teruo Kuroda; Takashi Higuchi; Takayuki Katoh; Hideaki E Kato; Motoyuki Hattori; Kaoru Kumazaki; Tomoya Tsukazaki; Ryuichiro Ishitani; Hiroaki Suga; Osamu Nureki
Journal:  Nature       Date:  2013-03-27       Impact factor: 49.962

5.  Residential proximity to large numbers of swine in feeding operations is associated with increased risk of methicillin-resistant Staphylococcus aureus colonization at time of hospital admission in rural Iowa veterans.

Authors:  Margaret Carrel; Marin L Schweizer; Mary Vaughan Sarrazin; Tara C Smith; Eli N Perencevich
Journal:  Infect Control Hosp Epidemiol       Date:  2014-01-08       Impact factor: 3.254

6.  Increasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003-2008.

Authors:  Michael Z David; Sofia Medvedev; Samuel F Hohmann; Bernard Ewigman; Robert S Daum
Journal:  Infect Control Hosp Epidemiol       Date:  2012-06-11       Impact factor: 3.254

7.  A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation.

Authors:  Colleen T O'Loughlin; Laura C Miller; Albert Siryaporn; Knut Drescher; Martin F Semmelhack; Bonnie L Bassler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-18       Impact factor: 11.205
  7 in total
  2 in total

1.  MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.

Authors:  C Benito-Villalvilla; C Cirauqui; C M Diez-Rivero; M Casanovas; J L Subiza; O Palomares
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

Review 2.  Biotechnological applications derived from microorganisms of the Atacama Desert.

Authors:  Armando Azua-Bustos; Carlos González-Silva
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.